Worst in class: Why our sharemarket performance is a global outlier
Australia's sharemarket underperformed with a gain of just 2.8 percent for the 2026 financial year, significantly lagging behind global markets. The ASX 200 index, heavily reliant on major companies, saw notable failures from CSL and Cochlear, while 4D Medical emerged as a standout with a staggering 1700 percent increase in share price.
Take it further — get the full app and never miss a moment of what's happening in Australia.
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
Published 01 Jul 2026, 05:58 UTC · Updated 01 Jul 2026, 06:00 UTC
Summary by OZbrief Editorial. Original report: SMH. Editorial policy · Corrections
Trending
- 'It's who we are': Albanese issues impassioned defence of multiculturalism
- Former CFMEU chief pleads for drug trafficker tied to Big Build corruption
- Katrina Kroetch showcases women's magic talent at Melbourne Magic Festival
- Paul Hogan has reportedly called Pauline Hanson a ‘pelican’. Please explain?
- Uganda's leading media outlets say they are under 'military siege'
- Football-free zone: Wimbledon extends World Cup screening ban to players’ lounge